R-CEOP as first-line treatment for anthracycline-ineligible patients with diffuse large B-cell lymphoma

oleh: Diana Al-Sarayfi, Frederik O. Meeuwes, Müjde Durmaz, Djamila E. Issa, Rolf E. Brouwer, Aart Beeker, Anna van Rhenen, Pim G. N. J. Mutsaers, Lara H. Böhmer, Marjolein W. M. van der Poel, Liane te Boome, Tom van Meerten, Martine E. D. Chamuleau, Josée M. Zijlstra, Mirian Brink, Marcel Nijland

Format: Article
Diterbitkan: Nature Publishing Group 2022-09-01

Deskripsi

No description available for this item.